Is SANA or SER more undervalued in 2026?

CirclFi compares Sana Biotechnology, Inc. (SANA) and Serina Therapeutics, Inc. (SER) using 13 institutional-grade valuation models. SANA has a Quality of Company score of 3.8/10 while SER scores 4.9/10.

Which is a better buy — SANA or SER?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SANA and SER valuations compare?

SANA at $3.13 and SER at $1.95 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SANA vs SER Valuation Comparison 2026 — Intrinsic Value Analysis

SANA

Biotechnology

Sana Biotechnology, Inc.

Quality

3.8

out of 10

Value Trap

LOW

Price

$3.13

Last close

Models

7/13

Active

SER

Biotechnology

Serina Therapeutics, Inc.

Quality

4.9

out of 10

Value Trap

LOW

Price

$1.95

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	SANA Fair Value	SANA Upside	SER Fair Value	SER Upside
Bayesian DCF	Intrinsic	$0.89	-71.4%	$1.20	-38.7%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.85	-72.9%	$0.40	-79.4%
Dynamic NAV	Asset-Based	$0.41	-86.8%	$2.49	+27.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SANA vs SER — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SANA vs SER — Which Stock Is More Undervalued?

SER scores higher with a 4.9/10 quality rating vs SANA's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Sana Biotechnology, Inc. (SANA) and Serina Therapeutics, Inc. (SER) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SANA currently trades at $3.13 with a QOC of 3.8/10, while SER trades at $1.95 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).